| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosome Aberrations | 129 | 2022 | 1768 | 5.600 |
Why?
|
| Translocation, Genetic | 114 | 2018 | 1393 | 4.880 |
Why?
|
| Karyotyping | 175 | 2017 | 1171 | 3.780 |
Why?
|
| In Situ Hybridization, Fluorescence | 127 | 2023 | 2510 | 3.280 |
Why?
|
| Chromosomes, Human, Pair 12 | 46 | 2018 | 430 | 2.550 |
Why?
|
| Lipoma | 37 | 2013 | 293 | 2.380 |
Why?
|
| Soft Tissue Neoplasms | 47 | 2022 | 1159 | 2.180 |
Why?
|
| Cytogenetics | 21 | 2022 | 198 | 1.940 |
Why?
|
| Chromosomes, Human, Pair 1 | 26 | 2015 | 638 | 1.800 |
Why?
|
| Oncogene Proteins, Fusion | 34 | 2023 | 1609 | 1.750 |
Why?
|
| Chromosomes, Human, Pair 6 | 19 | 2024 | 367 | 1.580 |
Why?
|
| Chromosome Banding | 63 | 2016 | 260 | 1.580 |
Why?
|
| Chromosome Deletion | 30 | 2024 | 1386 | 1.560 |
Why?
|
| Chromosomes, Human, Pair 17 | 23 | 2014 | 418 | 1.560 |
Why?
|
| Cytogenetic Analysis | 23 | 2022 | 270 | 1.530 |
Why?
|
| Chromosomes, Human, Pair 11 | 21 | 2013 | 410 | 1.490 |
Why?
|
| Trisomy | 21 | 2016 | 260 | 1.470 |
Why?
|
| Uterine Neoplasms | 38 | 2020 | 1420 | 1.450 |
Why?
|
| Kidney Neoplasms | 37 | 2020 | 4251 | 1.440 |
Why?
|
| Gene Rearrangement | 34 | 2023 | 1125 | 1.420 |
Why?
|
| High Mobility Group Proteins | 16 | 2002 | 177 | 1.220 |
Why?
|
| HMGA2 Protein | 19 | 2017 | 102 | 1.200 |
Why?
|
| Chromosomes, Human, Pair 7 | 18 | 2007 | 310 | 1.170 |
Why?
|
| Carcinoma, Renal Cell | 23 | 2020 | 3165 | 1.110 |
Why?
|
| Leiomyoma | 27 | 2016 | 636 | 1.070 |
Why?
|
| Fibrosarcoma | 12 | 2022 | 309 | 1.060 |
Why?
|
| Leukemia, Myeloid, Acute | 24 | 2022 | 3615 | 1.000 |
Why?
|
| Chromosome Disorders | 22 | 2011 | 497 | 0.990 |
Why?
|
| Chromosomes, Human, Pair 8 | 16 | 2017 | 453 | 0.980 |
Why?
|
| Myelodysplastic Syndromes | 12 | 2022 | 1394 | 0.940 |
Why?
|
| Chromosomes, Human, Pair 20 | 8 | 2011 | 127 | 0.900 |
Why?
|
| Polyps | 12 | 2021 | 200 | 0.900 |
Why?
|
| Chromosomes, Human | 11 | 2017 | 441 | 0.890 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 | 2024 | 1640 | 0.840 |
Why?
|
| Liposarcoma | 18 | 2015 | 289 | 0.800 |
Why?
|
| Metaphase | 9 | 2012 | 145 | 0.790 |
Why?
|
| Chromosomes, Human, Pair 22 | 17 | 2008 | 346 | 0.750 |
Why?
|
| Myeloproliferative Disorders | 5 | 2022 | 613 | 0.730 |
Why?
|
| Transcription Factors | 29 | 2023 | 12130 | 0.700 |
Why?
|
| Chromosomes, Human, Pair 9 | 13 | 2011 | 535 | 0.700 |
Why?
|
| Neoplasms, Muscle Tissue | 5 | 2020 | 67 | 0.670 |
Why?
|
| Fibroma | 10 | 2010 | 190 | 0.660 |
Why?
|
| Adenosarcoma | 5 | 2021 | 36 | 0.650 |
Why?
|
| Chromosomes, Human, Pair 15 | 11 | 2013 | 361 | 0.640 |
Why?
|
| Gene Amplification | 12 | 2015 | 1089 | 0.630 |
Why?
|
| Janus Kinase 2 | 4 | 2011 | 560 | 0.630 |
Why?
|
| Chromosomes, Human, Pair 16 | 13 | 2010 | 343 | 0.630 |
Why?
|
| DNA-Binding Proteins | 25 | 2023 | 9610 | 0.610 |
Why?
|
| Neoplasm Proteins | 24 | 2018 | 3617 | 0.600 |
Why?
|
| Leiomyosarcoma | 15 | 2016 | 422 | 0.600 |
Why?
|
| Sarcoma | 20 | 2018 | 1801 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 14 | 12 | 2011 | 287 | 0.570 |
Why?
|
| Isochromosomes | 3 | 2018 | 16 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 19 | 6 | 2009 | 350 | 0.570 |
Why?
|
| Endometrial Neoplasms | 10 | 2017 | 1366 | 0.560 |
Why?
|
| Immunohistochemistry | 46 | 2022 | 11076 | 0.560 |
Why?
|
| Sarcoma, Endometrial Stromal | 7 | 2017 | 93 | 0.560 |
Why?
|
| Chromosomes, Human, Pair 2 | 8 | 2004 | 313 | 0.530 |
Why?
|
| Chromosomes, Human, Pair 3 | 10 | 2012 | 322 | 0.520 |
Why?
|
| Chromosomes, Human, Y | 2 | 2021 | 161 | 0.510 |
Why?
|
| Humans | 426 | 2024 | 761596 | 0.510 |
Why?
|
| Leiomyomatosis | 5 | 2016 | 69 | 0.510 |
Why?
|
| Salivary Gland Neoplasms | 5 | 2023 | 304 | 0.490 |
Why?
|
| Burkitt Lymphoma | 5 | 2022 | 335 | 0.490 |
Why?
|
| Adenoma, Oxyphilic | 5 | 2001 | 148 | 0.490 |
Why?
|
| Thrombocythemia, Essential | 2 | 2018 | 113 | 0.480 |
Why?
|
| Ring Chromosomes | 8 | 2017 | 26 | 0.460 |
Why?
|
| Chromosomes, Human, X | 5 | 2011 | 321 | 0.460 |
Why?
|
| Proto-Oncogenes | 3 | 2005 | 321 | 0.460 |
Why?
|
| Fibrous Dysplasia of Bone | 3 | 2000 | 53 | 0.450 |
Why?
|
| Hematologic Neoplasms | 4 | 2022 | 1896 | 0.440 |
Why?
|
| Oncogene Proteins | 6 | 2018 | 719 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 10 | 9 | 2012 | 277 | 0.440 |
Why?
|
| X Chromosome | 13 | 2001 | 816 | 0.430 |
Why?
|
| Genetic Markers | 28 | 2016 | 2601 | 0.430 |
Why?
|
| Female | 267 | 2024 | 392705 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 21 | 5 | 2005 | 228 | 0.420 |
Why?
|
| Eosinophilia | 4 | 2022 | 560 | 0.420 |
Why?
|
| Receptors, Steroid | 2 | 2023 | 156 | 0.420 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2023 | 62 | 0.410 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2022 | 1551 | 0.410 |
Why?
|
| Neoplasms, Second Primary | 5 | 2022 | 1052 | 0.400 |
Why?
|
| Bone Neoplasms | 13 | 2014 | 2529 | 0.400 |
Why?
|
| Lymphoma, B-Cell | 9 | 2017 | 940 | 0.390 |
Why?
|
| Bone Marrow | 12 | 2023 | 2911 | 0.390 |
Why?
|
| Monosomy | 6 | 2000 | 52 | 0.390 |
Why?
|
| Adult | 183 | 2023 | 221210 | 0.390 |
Why?
|
| RNA-Binding Protein EWS | 9 | 2018 | 210 | 0.380 |
Why?
|
| Ovarian Neoplasms | 9 | 2020 | 4878 | 0.380 |
Why?
|
| Middle Aged | 178 | 2024 | 220921 | 0.380 |
Why?
|
| Mesothelioma | 5 | 2018 | 807 | 0.370 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 8 | 2022 | 1626 | 0.370 |
Why?
|
| Teratoma | 3 | 2018 | 404 | 0.370 |
Why?
|
| Chromosome Inversion | 6 | 2012 | 120 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 5 | 7 | 2017 | 386 | 0.370 |
Why?
|
| Giant Cell Tumors | 6 | 2002 | 89 | 0.370 |
Why?
|
| Chromosome Mapping | 19 | 2009 | 4615 | 0.360 |
Why?
|
| Sarcoma, Synovial | 11 | 2012 | 153 | 0.360 |
Why?
|
| Pleural Neoplasms | 4 | 2019 | 609 | 0.360 |
Why?
|
| Dermatofibrosarcoma | 4 | 2001 | 48 | 0.350 |
Why?
|
| Primary Myelofibrosis | 2 | 2009 | 209 | 0.350 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2020 | 35 | 0.350 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 9 | 2016 | 1405 | 0.350 |
Why?
|
| Calmodulin-Binding Proteins | 5 | 2013 | 233 | 0.350 |
Why?
|
| Male | 213 | 2024 | 360846 | 0.340 |
Why?
|
| Bone Cysts, Aneurysmal | 4 | 2005 | 70 | 0.330 |
Why?
|
| Aged | 129 | 2024 | 169310 | 0.320 |
Why?
|
| Genes, myc | 2 | 2012 | 390 | 0.320 |
Why?
|
| Liposarcoma, Myxoid | 6 | 2012 | 60 | 0.320 |
Why?
|
| Carcinoma | 6 | 2023 | 2330 | 0.320 |
Why?
|
| Thrombocytosis | 1 | 2009 | 89 | 0.320 |
Why?
|
| Cytodiagnosis | 1 | 2013 | 447 | 0.320 |
Why?
|
| Hamartoma | 6 | 2000 | 235 | 0.310 |
Why?
|
| Neoplasms | 18 | 2020 | 22173 | 0.310 |
Why?
|
| Diagnosis, Differential | 28 | 2016 | 12973 | 0.310 |
Why?
|
| Prenatal Diagnosis | 2 | 2016 | 1265 | 0.310 |
Why?
|
| Testicular Neoplasms | 5 | 2023 | 799 | 0.310 |
Why?
|
| Gene Fusion | 5 | 2022 | 356 | 0.300 |
Why?
|
| Dupuytren Contracture | 2 | 1999 | 66 | 0.300 |
Why?
|
| Smooth Muscle Tumor | 3 | 2016 | 63 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2016 | 988 | 0.300 |
Why?
|
| Oncogenes | 5 | 2023 | 1222 | 0.290 |
Why?
|
| Nuclear Proteins | 9 | 2019 | 5799 | 0.290 |
Why?
|
| Protein-Tyrosine Kinases | 7 | 2016 | 2425 | 0.290 |
Why?
|
| Pineal Gland | 2 | 1998 | 158 | 0.290 |
Why?
|
| Uterine Diseases | 2 | 2021 | 108 | 0.280 |
Why?
|
| High-Throughput Nucleotide Sequencing | 10 | 2021 | 3639 | 0.270 |
Why?
|
| Hypertriglyceridemia | 1 | 2010 | 293 | 0.270 |
Why?
|
| Gene Deletion | 9 | 2019 | 2665 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 6 | 2015 | 368 | 0.270 |
Why?
|
| Angiomyolipoma | 2 | 1998 | 187 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2014 | 8554 | 0.270 |
Why?
|
| Adenoma | 9 | 2001 | 2163 | 0.270 |
Why?
|
| Tendons | 3 | 2002 | 558 | 0.270 |
Why?
|
| Fibromatosis, Aggressive | 4 | 2000 | 126 | 0.260 |
Why?
|
| Aged, 80 and over | 61 | 2021 | 58984 | 0.260 |
Why?
|
| Mediastinal Neoplasms | 4 | 2017 | 401 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 18 | 7 | 2007 | 247 | 0.250 |
Why?
|
| Receptors, Thyroid Hormone | 3 | 2023 | 199 | 0.250 |
Why?
|
| Germinoma | 4 | 2004 | 132 | 0.250 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2018 | 502 | 0.250 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 746 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 17904 | 0.240 |
Why?
|
| Myofibroma | 3 | 2015 | 45 | 0.240 |
Why?
|
| DNA, Neoplasm | 19 | 2012 | 1745 | 0.240 |
Why?
|
| Muscle Neoplasms | 3 | 2001 | 130 | 0.240 |
Why?
|
| HMGA1a Protein | 9 | 2000 | 61 | 0.230 |
Why?
|
| Leukemia | 5 | 2022 | 1522 | 0.230 |
Why?
|
| Mucin-4 | 3 | 2014 | 33 | 0.230 |
Why?
|
| Leukemia, Myeloid | 2 | 2005 | 694 | 0.230 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2018 | 431 | 0.230 |
Why?
|
| Gene Expression Profiling | 18 | 2021 | 9420 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 20 | 2007 | 6131 | 0.220 |
Why?
|
| Chondrosarcoma | 8 | 2008 | 296 | 0.220 |
Why?
|
| Hypotension | 1 | 2010 | 879 | 0.220 |
Why?
|
| Mutation | 18 | 2024 | 30053 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 17 | 2015 | 4576 | 0.220 |
Why?
|
| Lung Neoplasms | 15 | 2021 | 13381 | 0.220 |
Why?
|
| Myxosarcoma | 2 | 2022 | 11 | 0.210 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2018 | 686 | 0.210 |
Why?
|
| Oncogene Fusion | 3 | 2017 | 81 | 0.210 |
Why?
|
| Thymoma | 2 | 1996 | 188 | 0.210 |
Why?
|
| Lymphoma, Mantle-Cell | 2 | 2021 | 237 | 0.210 |
Why?
|
| RNA-Binding Proteins | 6 | 2013 | 1898 | 0.210 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 184 | 0.210 |
Why?
|
| Adolescent | 71 | 2022 | 88326 | 0.210 |
Why?
|
| Nephroma, Mesoblastic | 2 | 2001 | 24 | 0.200 |
Why?
|
| Phyllodes Tumor | 3 | 1998 | 53 | 0.200 |
Why?
|
| Granuloma, Plasma Cell | 4 | 2010 | 80 | 0.200 |
Why?
|
| Fever | 1 | 2010 | 1618 | 0.200 |
Why?
|
| Thymus Neoplasms | 2 | 1996 | 274 | 0.200 |
Why?
|
| Myoepithelioma | 2 | 2013 | 26 | 0.200 |
Why?
|
| Ribosomal Proteins | 1 | 2024 | 371 | 0.200 |
Why?
|
| Trans-Activators | 5 | 2007 | 2856 | 0.190 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 3 | 2018 | 491 | 0.190 |
Why?
|
| Cell Nucleus | 6 | 2023 | 2910 | 0.190 |
Why?
|
| Endometrial Stromal Tumors | 2 | 2015 | 46 | 0.190 |
Why?
|
| Vulvar Neoplasms | 3 | 2010 | 263 | 0.190 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2023 | 118 | 0.190 |
Why?
|
| Y Chromosome | 6 | 1999 | 205 | 0.190 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2001 | 162 | 0.180 |
Why?
|
| 14-3-3 Proteins | 2 | 2012 | 220 | 0.180 |
Why?
|
| Neoplasms, Multiple Primary | 5 | 2021 | 592 | 0.180 |
Why?
|
| Nerve Sheath Neoplasms | 5 | 2001 | 170 | 0.180 |
Why?
|
| Carcinoma, Embryonal | 2 | 2009 | 37 | 0.180 |
Why?
|
| Granulosa Cell Tumor | 2 | 1999 | 77 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 1999 | 375 | 0.180 |
Why?
|
| Aneuploidy | 4 | 1998 | 552 | 0.180 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2001 | 217 | 0.180 |
Why?
|
| Prognosis | 21 | 2024 | 29629 | 0.180 |
Why?
|
| Neoplasms, Fibrous Tissue | 2 | 1999 | 20 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 13 | 4 | 1999 | 192 | 0.180 |
Why?
|
| Clone Cells | 7 | 2016 | 1659 | 0.170 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 2016 | 176 | 0.170 |
Why?
|
| Haploidy | 2 | 2011 | 126 | 0.170 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2021 | 92 | 0.170 |
Why?
|
| Abdominal Neoplasms | 2 | 2012 | 287 | 0.170 |
Why?
|
| Nuclear Envelope | 1 | 2021 | 163 | 0.170 |
Why?
|
| Chordoma | 2 | 2002 | 347 | 0.170 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2014 | 682 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2020 | 79 | 0.170 |
Why?
|
| Tenosynovitis | 2 | 1999 | 57 | 0.170 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2004 | 604 | 0.170 |
Why?
|
| Fibroma, Desmoplastic | 1 | 1999 | 6 | 0.170 |
Why?
|
| Adenoma, Pleomorphic | 2 | 2017 | 75 | 0.170 |
Why?
|
| Histiocytoma, Malignant Fibrous | 2 | 2011 | 55 | 0.170 |
Why?
|
| Solitary Fibrous Tumor, Pleural | 1 | 2019 | 25 | 0.170 |
Why?
|
| Philadelphia Chromosome | 1 | 2020 | 117 | 0.170 |
Why?
|
| Prostatic Hyperplasia | 2 | 2021 | 521 | 0.160 |
Why?
|
| Glioma, Subependymal | 1 | 1999 | 3 | 0.160 |
Why?
|
| Immunophenotyping | 13 | 2022 | 1869 | 0.160 |
Why?
|
| Vascular Neoplasms | 2 | 2016 | 166 | 0.160 |
Why?
|
| Diagnostic Errors | 4 | 2021 | 1265 | 0.160 |
Why?
|
| RNA Helicases | 1 | 2020 | 144 | 0.160 |
Why?
|
| Antigens, Neoplasm | 3 | 2020 | 1993 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2015 | 4514 | 0.160 |
Why?
|
| Recurrence | 7 | 2022 | 8466 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2022 | 2917 | 0.160 |
Why?
|
| RNA-Binding Protein FUS | 3 | 2012 | 76 | 0.160 |
Why?
|
| Myometrium | 4 | 2011 | 174 | 0.160 |
Why?
|
| Kidney Pelvis | 1 | 1999 | 186 | 0.150 |
Why?
|
| Ureteral Neoplasms | 1 | 1999 | 107 | 0.150 |
Why?
|
| Osteoblastoma | 1 | 1998 | 24 | 0.150 |
Why?
|
| Rhabdomyosarcoma | 3 | 2010 | 358 | 0.150 |
Why?
|
| Skull Neoplasms | 1 | 1999 | 173 | 0.150 |
Why?
|
| Brain Neoplasms | 7 | 2010 | 9032 | 0.150 |
Why?
|
| Molecular Biology | 2 | 2023 | 576 | 0.150 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2020 | 116 | 0.150 |
Why?
|
| Mesonephroma | 2 | 2015 | 21 | 0.150 |
Why?
|
| Peritoneal Neoplasms | 2 | 2018 | 711 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2011 | 3537 | 0.150 |
Why?
|
| Fibroadenoma | 1 | 1998 | 41 | 0.150 |
Why?
|
| Genomic Instability | 3 | 2020 | 709 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 4 | 5 | 2013 | 561 | 0.150 |
Why?
|
| Young Adult | 27 | 2023 | 59260 | 0.150 |
Why?
|
| Telomere | 4 | 2003 | 943 | 0.150 |
Why?
|
| Synovial Membrane | 3 | 2002 | 532 | 0.150 |
Why?
|
| Osteoma, Osteoid | 1 | 1998 | 90 | 0.150 |
Why?
|
| In Situ Hybridization | 8 | 2016 | 1900 | 0.150 |
Why?
|
| Calreticulin | 1 | 2018 | 114 | 0.140 |
Why?
|
| Mosaicism | 1 | 2021 | 475 | 0.140 |
Why?
|
| Epithelioid Cells | 2 | 2014 | 60 | 0.140 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 226 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 257 | 0.140 |
Why?
|
| Collagen | 4 | 2000 | 2638 | 0.140 |
Why?
|
| Chloride Channels | 1 | 2018 | 221 | 0.140 |
Why?
|
| Intestinal Neoplasms | 2 | 1991 | 314 | 0.140 |
Why?
|
| Chondroma | 1 | 1997 | 53 | 0.140 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2013 | 1118 | 0.140 |
Why?
|
| Myxoma | 3 | 2006 | 114 | 0.140 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2017 | 55 | 0.140 |
Why?
|
| Sclerosis | 3 | 2014 | 210 | 0.140 |
Why?
|
| Ovarian Diseases | 1 | 1998 | 137 | 0.140 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2017 | 123 | 0.140 |
Why?
|
| Child | 49 | 2022 | 80158 | 0.140 |
Why?
|
| Pelvic Neoplasms | 1 | 2018 | 247 | 0.140 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1999 | 263 | 0.130 |
Why?
|
| Biopsy | 12 | 2018 | 6766 | 0.130 |
Why?
|
| Mitogens | 1 | 2016 | 230 | 0.130 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2016 | 82 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1997 | 286 | 0.130 |
Why?
|
| Carcinogens | 1 | 1998 | 452 | 0.130 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1996 | 103 | 0.130 |
Why?
|
| Remission Induction | 3 | 2019 | 2397 | 0.130 |
Why?
|
| Peripheral Nervous System Neoplasms | 4 | 2001 | 133 | 0.130 |
Why?
|
| Pyrazoles | 3 | 2020 | 2009 | 0.130 |
Why?
|
| Co-Repressor Proteins | 5 | 2023 | 190 | 0.130 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 1739 | 0.130 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2016 | 97 | 0.130 |
Why?
|
| Pancytopenia | 1 | 2016 | 102 | 0.130 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1996 | 101 | 0.120 |
Why?
|
| Esophageal Neoplasms | 2 | 2017 | 1654 | 0.120 |
Why?
|
| Histiocytoma, Benign Fibrous | 4 | 2000 | 64 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2011 | 40 | 0.120 |
Why?
|
| Adipocytes | 3 | 2012 | 1194 | 0.120 |
Why?
|
| Fibromatosis, Abdominal | 1 | 1994 | 21 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 1997 | 372 | 0.120 |
Why?
|
| DNA Copy Number Variations | 2 | 2014 | 2020 | 0.120 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 332 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2016 | 2571 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2020 | 851 | 0.120 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2016 | 779 | 0.120 |
Why?
|
| Adamantinoma | 1 | 2014 | 9 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2011 | 3779 | 0.120 |
Why?
|
| Breast Diseases | 1 | 1997 | 442 | 0.110 |
Why?
|
| Mesenchymoma | 3 | 2004 | 49 | 0.110 |
Why?
|
| DNA Mutational Analysis | 4 | 2018 | 4111 | 0.110 |
Why?
|
| Pyrroles | 2 | 2010 | 1125 | 0.110 |
Why?
|
| Neoplasm, Residual | 1 | 2019 | 1008 | 0.110 |
Why?
|
| Femoral Neoplasms | 1 | 2014 | 84 | 0.110 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2013 | 33 | 0.110 |
Why?
|
| Hemosiderosis | 2 | 2011 | 66 | 0.110 |
Why?
|
| Tamoxifen | 1 | 1998 | 965 | 0.110 |
Why?
|
| Odontogenic Tumors | 1 | 1993 | 45 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2011 | 318 | 0.110 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2010 | 91 | 0.110 |
Why?
|
| Endometrium | 2 | 1998 | 403 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2022 | 9280 | 0.110 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2014 | 77 | 0.110 |
Why?
|
| WT1 Proteins | 1 | 2013 | 184 | 0.100 |
Why?
|
| Carcinoid Tumor | 1 | 2014 | 224 | 0.100 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2014 | 125 | 0.100 |
Why?
|
| Mandibular Neoplasms | 1 | 1993 | 130 | 0.100 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1999 | 783 | 0.100 |
Why?
|
| Cyclin D1 | 2 | 2012 | 451 | 0.100 |
Why?
|
| Repressor Proteins | 4 | 2017 | 2986 | 0.100 |
Why?
|
| Hodgkin Disease | 2 | 2015 | 1378 | 0.100 |
Why?
|
| Thyroid Neoplasms | 2 | 1999 | 2332 | 0.100 |
Why?
|
| Thecoma | 1 | 1992 | 11 | 0.100 |
Why?
|
| Child, Preschool | 31 | 2018 | 42232 | 0.100 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2020 | 2223 | 0.100 |
Why?
|
| Disease-Free Survival | 7 | 2017 | 6815 | 0.100 |
Why?
|
| Indoles | 2 | 2010 | 1833 | 0.100 |
Why?
|
| Physical Chromosome Mapping | 2 | 2002 | 183 | 0.100 |
Why?
|
| Chondrosarcoma, Mesenchymal | 1 | 2011 | 12 | 0.100 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2013 | 168 | 0.100 |
Why?
|
| Keratin-19 | 2 | 2008 | 33 | 0.100 |
Why?
|
| Keratin-7 | 2 | 2008 | 55 | 0.100 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2005 | 305 | 0.100 |
Why?
|
| Lymphocyte Subsets | 1 | 1992 | 309 | 0.100 |
Why?
|
| Fatal Outcome | 5 | 2014 | 1835 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2017 | 4024 | 0.090 |
Why?
|
| Cell Cycle Proteins | 5 | 2018 | 3449 | 0.090 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2013 | 251 | 0.090 |
Why?
|
| Pyrimidines | 3 | 2020 | 3028 | 0.090 |
Why?
|
| Histone Acetyltransferases | 2 | 2011 | 336 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2023 | 2805 | 0.090 |
Why?
|
| Chromosome Breakage | 8 | 2004 | 159 | 0.090 |
Why?
|
| Genetic Variation | 2 | 2000 | 6567 | 0.090 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2011 | 136 | 0.090 |
Why?
|
| Zinc Fingers | 4 | 2017 | 579 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 1997 | 1092 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 7 | 2010 | 1704 | 0.090 |
Why?
|
| HMGA Proteins | 1 | 2010 | 7 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 382 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 1998 | 1520 | 0.090 |
Why?
|
| Trophoblastic Neoplasms | 1 | 2020 | 88 | 0.090 |
Why?
|
| Exons | 2 | 2011 | 2391 | 0.090 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 2022 | 163 | 0.090 |
Why?
|
| Disease Progression | 8 | 2017 | 13510 | 0.090 |
Why?
|
| Lymphocytosis | 1 | 2011 | 121 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2015 | 2020 | 0.090 |
Why?
|
| Proteoglycans | 2 | 2011 | 803 | 0.090 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2020 | 53 | 0.090 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.090 |
Why?
|
| Artificial Gene Fusion | 2 | 2001 | 56 | 0.090 |
Why?
|
| Dysgerminoma | 1 | 1989 | 66 | 0.090 |
Why?
|
| Hospitals | 1 | 2023 | 3883 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 302 | 0.090 |
Why?
|
| Stromal Cells | 3 | 2012 | 1330 | 0.080 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 223 | 0.080 |
Why?
|
| Survival Rate | 6 | 2017 | 12723 | 0.080 |
Why?
|
| Cell Dedifferentiation | 1 | 2010 | 122 | 0.080 |
Why?
|
| Kidney Cortex | 1 | 1989 | 169 | 0.080 |
Why?
|
| Phenylalanine | 1 | 2011 | 366 | 0.080 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 206 | 0.080 |
Why?
|
| Valine | 1 | 2011 | 408 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 1600 | 0.080 |
Why?
|
| Receptors, Cytokine | 1 | 2009 | 258 | 0.080 |
Why?
|
| Acute Disease | 6 | 2022 | 7237 | 0.080 |
Why?
|
| Mitosis | 4 | 2021 | 1188 | 0.080 |
Why?
|
| Breast Neoplasms | 6 | 2000 | 21019 | 0.080 |
Why?
|
| Loss of Heterozygosity | 3 | 2006 | 662 | 0.080 |
Why?
|
| Wilms Tumor | 2 | 2007 | 379 | 0.080 |
Why?
|
| Ebolavirus | 1 | 2011 | 251 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 727 | 0.080 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2010 | 124 | 0.080 |
Why?
|
| Genital Neoplasms, Female | 1 | 2014 | 532 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 287 | 0.080 |
Why?
|
| Skin Neoplasms | 7 | 2013 | 5821 | 0.080 |
Why?
|
| Apoptosis | 5 | 2016 | 9490 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2010 | 1406 | 0.080 |
Why?
|
| Cloning, Molecular | 6 | 2002 | 4174 | 0.070 |
Why?
|
| Tibia | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Infant | 20 | 2018 | 36193 | 0.070 |
Why?
|
| Sarcoma, Alveolar Soft Part | 2 | 2001 | 43 | 0.070 |
Why?
|
| Vidarabine | 1 | 2009 | 336 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 8 | 2010 | 6075 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 1374 | 0.070 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2020 | 276 | 0.070 |
Why?
|
| Adipose Tissue | 3 | 2001 | 3313 | 0.070 |
Why?
|
| Virus Internalization | 1 | 2011 | 497 | 0.070 |
Why?
|
| Base Sequence | 13 | 2011 | 12441 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1745 | 0.070 |
Why?
|
| Down Syndrome | 1 | 1996 | 901 | 0.070 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 88 | 0.070 |
Why?
|
| Chromosome Fragility | 2 | 2002 | 16 | 0.070 |
Why?
|
| Lipomatosis | 1 | 1988 | 112 | 0.070 |
Why?
|
| Gene Dosage | 3 | 2007 | 1218 | 0.070 |
Why?
|
| Nitrophenols | 1 | 2007 | 169 | 0.070 |
Why?
|
| Angiolipoma | 2 | 1997 | 11 | 0.070 |
Why?
|
| Alleles | 3 | 2019 | 6864 | 0.070 |
Why?
|
| Hysterectomy | 2 | 2010 | 857 | 0.070 |
Why?
|
| Vaginal Neoplasms | 1 | 2007 | 104 | 0.070 |
Why?
|
| Retroperitoneal Neoplasms | 3 | 1999 | 333 | 0.070 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2006 | 46 | 0.070 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2006 | 954 | 0.070 |
Why?
|
| Chromatin | 2 | 2017 | 2961 | 0.070 |
Why?
|
| Laryngeal Neoplasms | 2 | 2001 | 514 | 0.070 |
Why?
|
| Liver Neoplasms | 4 | 2005 | 4317 | 0.070 |
Why?
|
| Predictive Value of Tests | 8 | 2016 | 15266 | 0.070 |
Why?
|
| Interphase | 4 | 2011 | 228 | 0.070 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2006 | 72 | 0.070 |
Why?
|
| Lymphatic Metastasis | 3 | 2023 | 2915 | 0.070 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 478 | 0.070 |
Why?
|
| CpG Islands | 1 | 2010 | 1230 | 0.060 |
Why?
|
| Retrospective Studies | 18 | 2023 | 80647 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2011 | 4142 | 0.060 |
Why?
|
| Prostatic Neoplasms | 4 | 2021 | 11122 | 0.060 |
Why?
|
| Flow Cytometry | 6 | 2018 | 5870 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 5305 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1136 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2014 | 11742 | 0.060 |
Why?
|
| Thigh | 3 | 1997 | 241 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2451 | 0.060 |
Why?
|
| Molecular Sequence Data | 12 | 2012 | 17635 | 0.060 |
Why?
|
| Ependymoma | 1 | 1988 | 320 | 0.060 |
Why?
|
| Blotting, Southern | 6 | 2001 | 777 | 0.060 |
Why?
|
| Urachus | 1 | 2004 | 18 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 1990 | 1229 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2557 | 0.060 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 242 | 0.060 |
Why?
|
| Osteosarcoma | 3 | 2014 | 897 | 0.060 |
Why?
|
| Adenocarcinoma | 3 | 2017 | 6345 | 0.060 |
Why?
|
| Choriocarcinoma | 1 | 2004 | 121 | 0.060 |
Why?
|
| Follow-Up Studies | 10 | 2021 | 39106 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 727 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 6484 | 0.060 |
Why?
|
| Adenofibroma | 1 | 2003 | 25 | 0.060 |
Why?
|
| RNA, Neoplasm | 4 | 2010 | 750 | 0.060 |
Why?
|
| Antigens, CD34 | 2 | 1996 | 658 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2010 | 1475 | 0.050 |
Why?
|
| Lung Diseases | 1 | 1993 | 1909 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2004 | 231 | 0.050 |
Why?
|
| Desmin | 4 | 2007 | 99 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2017 | 2827 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 3 | 1991 | 3397 | 0.050 |
Why?
|
| Melanocytes | 1 | 2006 | 509 | 0.050 |
Why?
|
| Lymphoma | 2 | 2009 | 1901 | 0.050 |
Why?
|
| Chromosomes, Human, 16-18 | 3 | 1986 | 32 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2011 | 2872 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 2693 | 0.050 |
Why?
|
| Neoplasm Staging | 5 | 2017 | 11120 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 2865 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2003 | 178 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 1616 | 0.050 |
Why?
|
| Polyploidy | 2 | 2003 | 119 | 0.050 |
Why?
|
| Chondromatosis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 4740 | 0.050 |
Why?
|
| Keratins | 3 | 2006 | 498 | 0.050 |
Why?
|
| Biphenyl Compounds | 1 | 2007 | 1007 | 0.050 |
Why?
|
| Patient Admission | 1 | 2010 | 1367 | 0.050 |
Why?
|
| Cholesterol | 1 | 2011 | 2905 | 0.050 |
Why?
|
| Centrosome | 1 | 2003 | 209 | 0.050 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2002 | 103 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 1136 | 0.050 |
Why?
|
| Endometriosis | 1 | 2010 | 870 | 0.050 |
Why?
|
| Vulva | 1 | 2022 | 84 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2021 | 41495 | 0.050 |
Why?
|
| Seminoma | 1 | 2023 | 134 | 0.050 |
Why?
|
| Medical Oncology | 1 | 1993 | 2321 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2003 | 296 | 0.050 |
Why?
|
| World Health Organization | 2 | 2022 | 1322 | 0.050 |
Why?
|
| Carcinoma, Papillary | 1 | 2006 | 785 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 237 | 0.050 |
Why?
|
| Antigens, CD | 7 | 2007 | 4001 | 0.050 |
Why?
|
| Phenotype | 5 | 2019 | 16592 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 14665 | 0.050 |
Why?
|
| Neoplasm Metastasis | 6 | 2010 | 4915 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2001 | 783 | 0.050 |
Why?
|
| Cell Division | 4 | 2003 | 4465 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3701 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2019 | 455 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2000 | 104 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2004 | 774 | 0.040 |
Why?
|
| Treatment Outcome | 11 | 2016 | 64685 | 0.040 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2000 | 43 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2019 | 44 | 0.040 |
Why?
|
| Animal Population Groups | 1 | 1999 | 12 | 0.040 |
Why?
|
| Genomics | 3 | 2022 | 5821 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3492 | 0.040 |
Why?
|
| Time Factors | 7 | 2017 | 39969 | 0.040 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2000 | 118 | 0.040 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 1999 | 32 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2011 | 473 | 0.040 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 1999 | 122 | 0.040 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 1999 | 43 | 0.040 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 1999 | 36 | 0.040 |
Why?
|
| Cadherins | 1 | 2004 | 903 | 0.040 |
Why?
|
| Genes, APC | 1 | 1999 | 145 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 2020 | 285 | 0.040 |
Why?
|
| Elastic Tissue | 1 | 1999 | 66 | 0.040 |
Why?
|
| Animals | 12 | 2023 | 168475 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2004 | 697 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2021 | 2417 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2014 | 694 | 0.040 |
Why?
|
| Vincristine | 2 | 2014 | 1036 | 0.040 |
Why?
|
| Hypopharynx | 1 | 1998 | 53 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 750 | 0.040 |
Why?
|
| Aging, Premature | 1 | 1999 | 44 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2016 | 1892 | 0.040 |
Why?
|
| Survival Analysis | 4 | 2019 | 10090 | 0.040 |
Why?
|
| Cluster Analysis | 4 | 2008 | 2707 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2001 | 290 | 0.040 |
Why?
|
| Chondromatosis, Synovial | 1 | 1998 | 17 | 0.040 |
Why?
|
| Pharyngeal Neoplasms | 1 | 1998 | 113 | 0.040 |
Why?
|
| Adenoma, Chromophobe | 1 | 1998 | 16 | 0.040 |
Why?
|
| Pyridines | 1 | 2010 | 2875 | 0.040 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2001 | 359 | 0.040 |
Why?
|
| Breast Neoplasms, Male | 1 | 2000 | 219 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 1998 | 84 | 0.040 |
Why?
|
| Neurofibromin 2 | 1 | 2019 | 271 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 4937 | 0.040 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 1999 | 100 | 0.040 |
Why?
|
| Multiprotein Complexes | 2 | 2017 | 1120 | 0.040 |
Why?
|
| Uterus | 1 | 2002 | 649 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2014 | 13642 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 12690 | 0.040 |
Why?
|
| Mice, Nude | 4 | 2009 | 3614 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2003 | 605 | 0.040 |
Why?
|
| Plants | 1 | 1999 | 327 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2007 | 1979 | 0.040 |
Why?
|
| Transcription Factor CHOP | 1 | 1997 | 68 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1997 | 69 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2023 | 1756 | 0.040 |
Why?
|
| Ploidies | 3 | 2000 | 285 | 0.040 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 1996 | 12 | 0.030 |
Why?
|
| Fibronectins | 1 | 2020 | 723 | 0.030 |
Why?
|
| Up-Regulation | 3 | 2012 | 4125 | 0.030 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 16990 | 0.030 |
Why?
|
| Myositis | 1 | 1999 | 271 | 0.030 |
Why?
|
| Vagina | 1 | 2022 | 838 | 0.030 |
Why?
|
| Granulocytes | 1 | 2018 | 551 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 1999 | 542 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 698 | 0.030 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2735 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 618 | 0.030 |
Why?
|
| Cells, Cultured | 5 | 2017 | 18966 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 2016 | 155 | 0.030 |
Why?
|
| Histiocytic Sarcoma | 1 | 2016 | 40 | 0.030 |
Why?
|
| Mitotic Index | 1 | 2016 | 162 | 0.030 |
Why?
|
| Osteosarcoma, Juxtacortical | 1 | 1995 | 2 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2019 | 3606 | 0.030 |
Why?
|
| Salivary Glands | 1 | 2017 | 229 | 0.030 |
Why?
|
| Lung | 1 | 2014 | 10002 | 0.030 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 1987 | 161 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 1996 | 47 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2015 | 7859 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 1492 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2018 | 909 | 0.030 |
Why?
|
| Radiography | 2 | 2014 | 6965 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9177 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 397 | 0.030 |
Why?
|
| Piperazines | 2 | 2007 | 2523 | 0.030 |
Why?
|
| Multiple Myeloma | 2 | 2010 | 5146 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2007 | 1302 | 0.030 |
Why?
|
| Heart Neoplasms | 1 | 1999 | 362 | 0.030 |
Why?
|
| Gene Expression | 4 | 2011 | 7581 | 0.030 |
Why?
|
| Paraffin | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2016 | 186 | 0.030 |
Why?
|
| New York City | 1 | 2017 | 731 | 0.030 |
Why?
|
| Joint Diseases | 1 | 1999 | 459 | 0.030 |
Why?
|
| Amino Acid Sequence | 5 | 2011 | 13446 | 0.030 |
Why?
|
| Giant Cells | 1 | 1995 | 188 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 1998 | 764 | 0.030 |
Why?
|
| Eosinophils | 1 | 2000 | 950 | 0.030 |
Why?
|
| Muscle, Smooth | 2 | 2006 | 926 | 0.030 |
Why?
|
| Chromosomes, Artificial, Yeast | 3 | 2001 | 113 | 0.030 |
Why?
|
| Doxorubicin | 2 | 2014 | 2224 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.030 |
Why?
|
| Genome, Human | 3 | 2012 | 4425 | 0.030 |
Why?
|
| Microarray Analysis | 2 | 2008 | 750 | 0.030 |
Why?
|
| Homozygote | 1 | 1999 | 1776 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 2645 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 1998 | 570 | 0.030 |
Why?
|
| Pulmonary Blastoma | 1 | 1994 | 41 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5672 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 20100 | 0.030 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2014 | 105 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 348 | 0.030 |
Why?
|
| Clavicle | 1 | 1996 | 224 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 1999 | 1342 | 0.030 |
Why?
|
| Bone Diseases | 1 | 1997 | 418 | 0.030 |
Why?
|
| Spermatic Cord | 1 | 1993 | 23 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2014 | 302 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2014 | 241 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2002 | 1161 | 0.030 |
Why?
|
| Actins | 3 | 2007 | 2050 | 0.030 |
Why?
|
| Multigene Family | 1 | 1996 | 1076 | 0.030 |
Why?
|
| Genital Neoplasms, Male | 1 | 1993 | 68 | 0.030 |
Why?
|
| Prostate | 1 | 2021 | 1773 | 0.030 |
Why?
|
| Blast Crisis | 2 | 1991 | 102 | 0.030 |
Why?
|
| Formaldehyde | 1 | 2014 | 358 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5672 | 0.030 |
Why?
|
| Genes | 2 | 2001 | 1823 | 0.030 |
Why?
|
| Infant, Newborn | 6 | 2018 | 26202 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2000 | 980 | 0.030 |
Why?
|
| Transcription, Genetic | 4 | 2010 | 7593 | 0.030 |
Why?
|
| Terminology as Topic | 2 | 2010 | 1530 | 0.030 |
Why?
|
| Sertoli Cell Tumor | 1 | 1993 | 36 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 3124 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2006 | 1058 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 368 | 0.030 |
Why?
|
| DNA, Complementary | 3 | 2001 | 1991 | 0.030 |
Why?
|
| Premenopause | 1 | 1996 | 1039 | 0.020 |
Why?
|
| Chromosome Duplication | 1 | 2012 | 75 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2011 | 20 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 517 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2016 | 627 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 2012 | 170 | 0.020 |
Why?
|
| Niemann-Pick Diseases | 1 | 2011 | 27 | 0.020 |
Why?
|
| Marburg Virus Disease | 1 | 2011 | 11 | 0.020 |
Why?
|
| Inflammation | 3 | 2023 | 10774 | 0.020 |
Why?
|
| Marburgvirus | 1 | 2011 | 19 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2014 | 283 | 0.020 |
Why?
|
| Necrosis | 1 | 2016 | 1611 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1999 | 1423 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2016 | 868 | 0.020 |
Why?
|
| Esophagus | 1 | 2017 | 1033 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 169 | 0.020 |
Why?
|
| Viral Fusion Proteins | 1 | 2011 | 100 | 0.020 |
Why?
|
| RNA, Messenger | 4 | 2010 | 12794 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2014 | 732 | 0.020 |
Why?
|
| Utrophin | 1 | 2010 | 15 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2004 | 545 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 533 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 550 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2009 | 23447 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 135 | 0.020 |
Why?
|
| Dosage Forms | 1 | 2010 | 56 | 0.020 |
Why?
|
| Cough | 1 | 2014 | 594 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1996 | 1148 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1998 | 2209 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2010 | 416 | 0.020 |
Why?
|
| Adenine | 1 | 2016 | 987 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2010 | 42 | 0.020 |
Why?
|
| PAX7 Transcription Factor | 1 | 2010 | 55 | 0.020 |
Why?
|
| Biochemical Phenomena | 1 | 2010 | 58 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2011 | 256 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10451 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 2011 | 266 | 0.020 |
Why?
|
| Prednisone | 1 | 2014 | 1563 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 4415 | 0.020 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 1989 | 48 | 0.020 |
Why?
|
| Genes, jun | 1 | 2009 | 69 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 326 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2010 | 573 | 0.020 |
Why?
|
| Observer Variation | 1 | 2016 | 2606 | 0.020 |
Why?
|
| Urethral Neoplasms | 2 | 2006 | 37 | 0.020 |
Why?
|
| Extremities | 2 | 2008 | 867 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1998 | 1323 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 29890 | 0.020 |
Why?
|
| Mucins | 1 | 2012 | 568 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1997 | 1802 | 0.020 |
Why?
|
| Femur | 1 | 1995 | 1307 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 2220 | 0.020 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 2008 | 3 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 1 | 2011 | 376 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2014 | 11530 | 0.020 |
Why?
|
| Endosomes | 1 | 2011 | 522 | 0.020 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2008 | 60 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2832 | 0.020 |
Why?
|
| Menopause | 1 | 1996 | 1646 | 0.020 |
Why?
|
| Blood | 1 | 2010 | 596 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2014 | 20568 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 3430 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2011 | 640 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1988 | 310 | 0.020 |
Why?
|
| Pelvic Pain | 1 | 2010 | 298 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 899 | 0.020 |
Why?
|
| Mesoderm | 2 | 2001 | 674 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 3 | 2005 | 5790 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4281 | 0.020 |
Why?
|
| Mice | 6 | 2023 | 81539 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2643 | 0.020 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2009 | 178 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2010 | 582 | 0.020 |
Why?
|
| Piperidines | 1 | 2016 | 1656 | 0.020 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1987 | 58 | 0.020 |
Why?
|
| Chest Pain | 1 | 2014 | 1091 | 0.020 |
Why?
|
| Ankle | 1 | 2010 | 351 | 0.020 |
Why?
|
| Alternative Splicing | 2 | 2003 | 1093 | 0.020 |
Why?
|
| Cell Line | 4 | 2011 | 15601 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2010 | 815 | 0.020 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2006 | 26 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5368 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 2091 | 0.020 |
Why?
|
| Chromosomes | 1 | 1990 | 578 | 0.020 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1986 | 45 | 0.020 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1986 | 69 | 0.020 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 1986 | 49 | 0.020 |
Why?
|
| Hybrid Cells | 2 | 1998 | 422 | 0.020 |
Why?
|
| Cartilage | 1 | 2010 | 806 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 571 | 0.020 |
Why?
|
| Dyspnea | 1 | 2014 | 1347 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2008 | 346 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1986 | 112 | 0.020 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2011 | 420 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2022 | 4652 | 0.020 |
Why?
|
| Leg | 1 | 1991 | 1088 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 1967 | 0.020 |
Why?
|
| Hemangiopericytoma | 1 | 1986 | 71 | 0.020 |
Why?
|
| Etoposide | 1 | 2007 | 634 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 924 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 3792 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2006 | 191 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2010 | 610 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2010 | 2115 | 0.020 |
Why?
|
| Sex Factors | 2 | 2015 | 10554 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2009 | 531 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2010 | 1784 | 0.020 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2004 | 46 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3677 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 878 | 0.020 |
Why?
|
| Urachal Cyst | 1 | 2004 | 7 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2010 | 12463 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1989 | 728 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9327 | 0.010 |
Why?
|
| DNA Probes | 2 | 1998 | 541 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1997 | 4369 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 2003 | 44 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2007 | 1646 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 18255 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2008 | 836 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 647 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2003 | 48 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2003 | 71 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2011 | 2203 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 4431 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2007 | 678 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2007 | 621 | 0.010 |
Why?
|
| Publishing | 1 | 2010 | 833 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1997 | 4580 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 1991 | 1351 | 0.010 |
Why?
|
| Hemangiosarcoma | 1 | 2005 | 215 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8833 | 0.010 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 1459 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 4807 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 858 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 2004 | 457 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 2004 | 496 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 2003 | 189 | 0.010 |
Why?
|
| Genes, Neoplasm | 1 | 2004 | 370 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2014 | 36426 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 341 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 436 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1994 | 851 | 0.010 |
Why?
|
| Chondroblastoma | 1 | 2002 | 47 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2005 | 557 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 1134 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 2003 | 255 | 0.010 |
Why?
|
| Osteochondroma | 1 | 2002 | 44 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2005 | 616 | 0.010 |
Why?
|
| Survival | 1 | 2002 | 161 | 0.010 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2001 | 56 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1988 | 1206 | 0.010 |
Why?
|
| Epiglottis | 1 | 2001 | 81 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 11904 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1989 | 2932 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 123 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1171 | 0.010 |
Why?
|
| Testis | 1 | 2004 | 794 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2003 | 392 | 0.010 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2001 | 56 | 0.010 |
Why?
|
| S100 Proteins | 1 | 2001 | 218 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1601 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 1595 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2002 | 207 | 0.010 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2001 | 38 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2001 | 315 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 2010 | 1265 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 903 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1994 | 2561 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2012 | 15936 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2010 | 3396 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 378 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2000 | 132 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 5035 | 0.010 |
Why?
|
| Ganglioglioma | 1 | 1999 | 36 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 1999 | 19 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2001 | 261 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3465 | 0.010 |
Why?
|
| Periodicals as Topic | 1 | 2010 | 1463 | 0.010 |
Why?
|
| Protein Binding | 1 | 2012 | 9353 | 0.010 |
Why?
|
| Neurofibroma | 1 | 2000 | 95 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2828 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5247 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1993 | 2894 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 2036 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 2919 | 0.010 |
Why?
|
| Myosarcoma | 1 | 1998 | 1 | 0.010 |
Why?
|
| Immunity | 1 | 2004 | 996 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8527 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 1999 | 293 | 0.010 |
Why?
|
| Axilla | 1 | 2001 | 624 | 0.010 |
Why?
|
| Estrogen Receptor beta | 1 | 1998 | 168 | 0.010 |
Why?
|
| Pancreas | 1 | 2004 | 1691 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22176 | 0.010 |
Why?
|
| Oligodendroglioma | 1 | 1999 | 279 | 0.010 |
Why?
|
| Veins | 1 | 2002 | 768 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1999 | 309 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2006 | 2490 | 0.010 |
Why?
|
| Nucleic Acid Probes | 1 | 1997 | 9 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1998 | 255 | 0.010 |
Why?
|
| Proteins | 2 | 2003 | 6032 | 0.010 |
Why?
|
| Prolactinoma | 1 | 1998 | 114 | 0.010 |
Why?
|
| Appendicitis | 1 | 2004 | 675 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 8633 | 0.010 |
Why?
|
| Incidence | 2 | 2011 | 21355 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2898 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1699 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 3514 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2000 | 1574 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1999 | 1122 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 655 | 0.010 |
Why?
|
| Belgium | 1 | 1996 | 118 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 427 | 0.010 |
Why?
|
| Telomerase | 1 | 2001 | 745 | 0.010 |
Why?
|
| Cosmids | 1 | 1996 | 105 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2001 | 2626 | 0.010 |
Why?
|
| Prolactin | 1 | 1998 | 625 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 1968 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2000 | 1085 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72340 | 0.010 |
Why?
|
| Anemia, Refractory | 1 | 1995 | 17 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3415 | 0.010 |
Why?
|
| Benzamides | 1 | 2001 | 1371 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1997 | 562 | 0.010 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 1995 | 38 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2000 | 1702 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1997 | 602 | 0.010 |
Why?
|
| Algorithms | 1 | 2016 | 14033 | 0.010 |
Why?
|
| Tyrosine | 1 | 1999 | 1440 | 0.010 |
Why?
|
| Edema | 1 | 1999 | 766 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 2820 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1494 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12059 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 7396 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1999 | 1626 | 0.010 |
Why?
|
| Neurilemmoma | 1 | 2000 | 526 | 0.010 |
Why?
|
| beta Catenin | 1 | 1999 | 1040 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1998 | 834 | 0.010 |
Why?
|
| Italy | 1 | 1996 | 842 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 2725 | 0.010 |
Why?
|
| Fluorescence | 1 | 1996 | 756 | 0.010 |
Why?
|
| Lymphocytes | 2 | 1994 | 2612 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2001 | 3597 | 0.010 |
Why?
|
| DNA | 2 | 1999 | 7213 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 1998 | 642 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2001 | 3605 | 0.010 |
Why?
|
| Scoliosis | 1 | 1999 | 741 | 0.010 |
Why?
|
| Vimentin | 1 | 1993 | 255 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2005 | 2297 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6214 | 0.010 |
Why?
|
| Myosins | 1 | 1993 | 405 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 5791 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1991 | 101 | 0.010 |
Why?
|
| Age Factors | 2 | 1998 | 18399 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1991 | 66 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2001 | 2645 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1995 | 1510 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1991 | 257 | 0.010 |
Why?
|
| Meningioma | 1 | 1999 | 1218 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1992 | 283 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 1991 | 211 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2000 | 3442 | 0.010 |
Why?
|
| Erythroblasts | 1 | 1990 | 142 | 0.010 |
Why?
|
| Centromere | 1 | 1991 | 212 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2009 | 54423 | 0.010 |
Why?
|
| Melanoma | 1 | 1988 | 5709 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2000 | 2747 | 0.000 |
Why?
|
| Knee Joint | 1 | 1997 | 1676 | 0.000 |
Why?
|
| Muscles | 1 | 1993 | 1576 | 0.000 |
Why?
|
| Syndrome | 1 | 1995 | 3267 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1999 | 8321 | 0.000 |
Why?
|
| Chromosome Fragile Sites | 1 | 1988 | 26 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2010 | 23996 | 0.000 |
Why?
|
| Methylation | 1 | 1990 | 1084 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2002 | 12341 | 0.000 |
Why?
|
| Rabbits | 1 | 1994 | 4772 | 0.000 |
Why?
|
| Liver | 1 | 2003 | 7528 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 5485 | 0.000 |
Why?
|
| Culture Media | 1 | 1986 | 897 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 4948 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1988 | 2016 | 0.000 |
Why?
|
| Kidney | 1 | 2000 | 7048 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1999 | 3483 | 0.000 |
Why?
|
| Stem Cells | 1 | 1996 | 3524 | 0.000 |
Why?
|
| Transfection | 1 | 1991 | 5774 | 0.000 |
Why?
|
| Prevalence | 1 | 1998 | 15733 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1988 | 2386 | 0.000 |
Why?
|
| Glioma | 1 | 1991 | 3455 | 0.000 |
Why?
|
| Risk Factors | 1 | 2000 | 74213 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1988 | 10194 | 0.000 |
Why?
|